1.Photodynamic hyperthermal chemotherapy with indocyanine green: a novel cancer therapy for 16 cases of malignant soft tissue sarcoma.
Masaki ONOYAMA ; Takeshi TSUKA ; Tomohiro IMAGAWA ; Tomohiro OSAKI ; Saburo MINAMI ; Kazuo AZUMA ; Kazuhiko KAWASHIMA ; Hiroshi ISHI ; Takahiro TAKAYAMA ; Nobuhiko OGAWA ; Yoshiharu OKAMOTO
Journal of Veterinary Science 2014;15(1):117-123
Sixteen cases of malignant soft tissue sarcoma (STS; 10 canines and six felines) were treated with a novel triple therapy that combined photodynamic therapy, hyperthermia using indocyanine green with a broadband light source, and local chemotherapy after surgical tumor resection. This triple therapy was called photodynamic hyperthermal chemotherapy (PHCT). In all cases, the surgical margin was insufficient. In one feline case, PHCT was performed without surgical resection. PHCT was performed over an interval of 1 to 2 weeks and was repeated three to 21 times. No severe side effects, including severe skin burns, necrosis, or skin suture rupture, were observed in any of the animals. No disease recurrence was observed in seven out of 10 (70.0%) dogs and three out of six (50.0%) cats over the follow-up periods ranging from 238 to 1901 days. These results suggest that PHCT decreases the risk of STS recurrence. PHCT should therefore be considered an adjuvant therapy for treating companion animals with STS in veterinary medicine.
Animals
;
Antineoplastic Agents/*therapeutic use
;
Cat Diseases/drug therapy/surgery/*therapy
;
Cats
;
Combined Modality Therapy/veterinary
;
Dog Diseases/drug therapy/surgery/*therapy
;
Dogs
;
Hyperthermia, Induced/veterinary
;
Indocyanine Green/*therapeutic use
;
Photochemotherapy/veterinary
;
Photosensitizing Agents/*therapeutic use
;
Sarcoma/drug therapy/surgery/therapy/*veterinary
2.Predictive Factors for Intractability to Endoscopic Hemostasis in the Treatment of Bleeding Gastroduodenal Peptic Ulcers in Japanese Patients.
Naotaka OGASAWARA ; Mari MIZUNO ; Ryuta MASUI ; Yoshihiro KONDO ; Yoshiharu YAMAGUCHI ; Kenichiro YANAMOTO ; Hisatsugu NODA ; Noriko OKANIWA ; Makoto SASAKI ; Kunio KASUGAI
Clinical Endoscopy 2014;47(2):162-173
BACKGROUND/AIMS: Despite improvements in endoscopic hemostasis and pharmacological therapies, upper gastrointestinal (UGI) ulcers repeatedly bleed in 10% to 20% of patients, and those without early endoscopic reintervention or definitive surgery might be at a high risk for mortality. This study aimed to identify the risk factors for intractability to initial endoscopic hemostasis. METHODS: We analyzed intractability among 428 patients who underwent emergency endoscopy for bleeding UGI ulcers within 24 hours of arrival at the hospital. RESULTS: Durable hemostasis was achieved in 354 patients by using initial endoscopic procedures. Sixty-nine patients with Forrest types Ia, Ib, IIa, and IIb at the second-look endoscopy were considered intractable to the initial endoscopic hemostasis. Multivariate analysis indicated that age > or =70 years (odds ratio [OR], 2.06; 95% confidence interval [CI], 1.07 to 4.03), shock on admission (OR, 5.26; 95% CI, 2.43 to 11.6), hemoglobin <8.0 mg/dL (OR, 2.80; 95% CI, 1.39 to 5.91), serum albumin <3.3 g/dL (OR, 2.23; 95% CI, 1.07 to 4.89), exposed vessels with a diameter of > or =2 mm on the bottom of ulcers (OR, 4.38; 95% CI, 1.25 to 7.01), and Forrest type Ia and Ib (OR, 2.21; 95% CI, 1.33 to 3.00) predicted intractable endoscopic hemostasis. CONCLUSIONS: Various factors contribute to intractable endoscopic hemostasis. Careful observation after endoscopic hemostasis is important for patients at a high risk for incomplete hemostasis.
Asian Continental Ancestry Group*
;
Emergencies
;
Endoscopy
;
Hematemesis
;
Hemorrhage*
;
Hemostasis
;
Hemostasis, Endoscopic*
;
Humans
;
Melena
;
Mortality
;
Multivariate Analysis
;
Peptic Ulcer*
;
Risk Factors
;
Serum Albumin
;
Shock
;
Ulcer
3.Internet Survey of Japanese Patients With Chronic Constipation: Focus on Correlations Between Sleep Quality, Symptom Severity, and Quality of Life
Sayuri YAMAMOTO ; Yurika KAWAMURA ; Kazuhiro YAMAMOTO ; Yoshiharu YAMAGUCHI ; Yasuhiro TAMURA ; Shinya IZAWA ; Hiroaki NAKAGAWA ; Yoshinori WAKITA ; Yasutaka HIJIKATA ; Masahide EBI ; Yasushi FUNAKI ; Wataru OHASHI ; Naotaka OGASAWARA ; Makoto SASAKI ; Masato MAEKAWA ; Kunio KASUGAI
Journal of Neurogastroenterology and Motility 2021;27(4):602-611
Background/Aims:
Chronic constipation and lifestyle factors can affect sleep quality. We evaluated the relationship between chronic constipation and sleep in the Japanese population.
Methods:
This cross-sectional internet-based survey included 3000 subjects with constipation, classified according to sleep status (good/poor).Primary endpoints were Bristol stool form scale (BSFS) score and correlations between sleep disorder criteria of the Pittsburgh Sleep Quality Index (PSQI) and sleep status (good/poor sleep). Secondary endpoints included correlations between quality of life (QOL) and mood, medical, lifestyle, and sleep factors.
Results:
The proportion of participants with BSFS category 4 (normal stool) was significantly higher in the good sleep group (P < 0.001). Sleep disturbance (P < 0.05), sleep quality, and duration, use of hypnotic medication, and daytime dysfunction of PSQI (all P < 0.001) significantly correlated with poor sleep. In the poor sleep group, QOL was significantly worse and anxiety and depression levels were significantly higher (allP < 0.001) compared with the good sleep group. Anemia and smoking (both P < 0.05), recent body weight increases, and poor eating habits (all P < 0.001) were significantly higher in the poor sleep group. Male sex, onset associated with change in frequency of stools, sensation of incomplete evacuation for at least 25% of defecations, and manual maneuvers to facilitate at least 25% of defecations correlated with poor sleep.
Conclusions
Subjects with constipation and poor sleep experienced severe symptoms and had poor QOL. These data support the need for a multifocal treatment approach, including lifestyle advice and pharmacotherapy.
4.Internet Survey of Japanese Patients With Chronic Constipation: Focus on Correlations Between Sleep Quality, Symptom Severity, and Quality of Life
Sayuri YAMAMOTO ; Yurika KAWAMURA ; Kazuhiro YAMAMOTO ; Yoshiharu YAMAGUCHI ; Yasuhiro TAMURA ; Shinya IZAWA ; Hiroaki NAKAGAWA ; Yoshinori WAKITA ; Yasutaka HIJIKATA ; Masahide EBI ; Yasushi FUNAKI ; Wataru OHASHI ; Naotaka OGASAWARA ; Makoto SASAKI ; Masato MAEKAWA ; Kunio KASUGAI
Journal of Neurogastroenterology and Motility 2021;27(4):602-611
Background/Aims:
Chronic constipation and lifestyle factors can affect sleep quality. We evaluated the relationship between chronic constipation and sleep in the Japanese population.
Methods:
This cross-sectional internet-based survey included 3000 subjects with constipation, classified according to sleep status (good/poor).Primary endpoints were Bristol stool form scale (BSFS) score and correlations between sleep disorder criteria of the Pittsburgh Sleep Quality Index (PSQI) and sleep status (good/poor sleep). Secondary endpoints included correlations between quality of life (QOL) and mood, medical, lifestyle, and sleep factors.
Results:
The proportion of participants with BSFS category 4 (normal stool) was significantly higher in the good sleep group (P < 0.001). Sleep disturbance (P < 0.05), sleep quality, and duration, use of hypnotic medication, and daytime dysfunction of PSQI (all P < 0.001) significantly correlated with poor sleep. In the poor sleep group, QOL was significantly worse and anxiety and depression levels were significantly higher (allP < 0.001) compared with the good sleep group. Anemia and smoking (both P < 0.05), recent body weight increases, and poor eating habits (all P < 0.001) were significantly higher in the poor sleep group. Male sex, onset associated with change in frequency of stools, sensation of incomplete evacuation for at least 25% of defecations, and manual maneuvers to facilitate at least 25% of defecations correlated with poor sleep.
Conclusions
Subjects with constipation and poor sleep experienced severe symptoms and had poor QOL. These data support the need for a multifocal treatment approach, including lifestyle advice and pharmacotherapy.